Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02871167
NA

Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation

Sponsor: Centre Oscar Lambret

View on ClinicalTrials.gov

Summary

The aim of the study is to perform a French multicenter prospective interventional study in order to assess the feasibility and safety of ovarian hyperstimulation for oocyte / embryo cryopreservation in young women with breast cancer. The oncologic and reproductive benefit / risk ratio will be investigated in the oncology and reproductive area.

Official title: Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation (CHACRY-1501)

Key Details

Gender

FEMALE

Age Range

18 Years - 38 Years

Study Type

INTERVENTIONAL

Enrollment

140

Start Date

2016-12

Completion Date

2034-11

Last Updated

2026-03-18

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

Controlled ovarian hyperstimulation (COH)

After information and consent, patients are addressed to a reproductive medicine center. The COH will be performed according to a standardized protocol between surgery and the start of adjuvant chemotherapy. Follicular growth will be achieved with an antagonist protocol and by using high dose recombinant FSH (r-FSH). The triggering of the final follicular and oocyte maturation will be obtained by a GnRH (Gonadotropin Releasing Hormone) agonist injection in order to minimize the risk of ovarian hyper-stimulation.

PROCEDURE

Oocyte/embryo freezing

Egg or embryo freezing will be performed according to a standardized protocol: slow-freezing process for embryo; vitrification technique for oocytes. Cryopreserved oocytes and embryos will be stored in the biological bank of each reproductive medicine center (min. 10 years).

Locations (28)

Hôpital Jean Verdier

Bondy, France

Centre Aliénor d'Aquitaine, Hôpital Pellegrin

Bordeaux, France

CHU de Caen

Caen, France

Centre François Baclesse

Caen, France

Hôpital Antoine Béclère

Clamart, France

Centre Georges François LECLERC

Dijon, France

CHU de Dijon

Dijon, France

CHU REUNION site SUD

La Réunion, France

Centre Oscar Lambret

Lille, France

CHRU Hôpital Jeanne de Flandres

Lille, France

CHU Limoges

Limoges, France

CHU Lyon

Lyon, France

Centre Léon Bérard

Lyon, France

CHU La Conception

Marseille, France

Institut Paoli Calmette

Marseille, France

CHRU Montpellier

Montpellier, France

ICM - Val d'Aurelle

Montpellier, France

CHRU de Nancy

Nancy, France

Institut Curie

Paris, France

Hôpital Cochin

Paris, France

Hôpital TENON

Paris, France

CHU Rouen

Rouen, France

Centre Henri Becquerel

Rouen, France

Institut Curie

Saint-Cloud, France

Hôpital Universitaire de Strasbourg

Strasbourg, France

Oncopole-CHU Toulouse

Toulouse, France

Institut de Cancérologie de Lorraine

Vandœuvre-lès-Nancy, France

Institut Gustave Roussy

Villejuif, France